Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.52 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | HTR1D | P28221 | 2/20 | 0.36 |
| ▸ | RXRB | P28702 | 4/20 | 0.35 |
| ▸ | RXRA | P19793 | 3/20 | 0.35 |
| ▸ | RXRG | P48443 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28241863 | 0.97 | GABRA1 (0.50) | GABRA1GABRB2POLBKDM4EGAA | |
| SCHEMBL846677 | 0.94 | GABRA1 (0.46) | GABRA1GABRB2POLBKDM4EGAA | |
| SCHEMBL23915436 | 0.89 | GABRA1 (0.44) | GABRA1GABRB2POLBKDM4EGAA | |
| SCHEMBL29416703 | 0.89 | GABRA1 (0.44) | GABRA1GABRB2POLBKDM4EGAA | |
| SCHEMBL29436334 | 0.87 | RXRB (0.42) | GABRA1GABRB2POLBKDM4EGAA | |
| SCHEMBL23909387 | 0.87 | RXRB (0.42) | GABRA1GABRB2POLBKDM4EGAA | |
| SCHEMBL1104681 | 0.87 | NOTUM (0.47) | GABRA1GABRB2POLBMAPTS1PR1 | |
| SCHEMBL13278178 | 0.87 | GABRA1 (0.48) | GABRA1GABRB2POLBKDM4EGAA | |
| SCHEMBL31071024 | 0.86 | RXRB (0.41) | GABRA1GABRB2POLBKDM4EGAA | |
| SCHEMBL34460149 | 0.84 | POLB (0.41) | GABRA1GABRB2POLBMAPTHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 665 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122059975-A | Eight-membered ring condensed boron dipyrrole compound and preparation method thereof | 中国科学院宁波材料技术与工程研究所 | 2026-05-19 | — | — | CN | claimed |
| CN-115636736-B | Synthesis method of catalyst ligand material | 烟台海川化学制品有限公司 | 2023-05-12 | — | — | CN | claimed |
| CN-115636736-A | Synthesis method of catalyst ligand material | 烟台海川化学制品有限公司 | 2023-01-24 | — | — | CN | claimed |
| CN-112321639-A | Preparation method of aryl diphenylphosphine derivative | 河南省科学院化学研究所有限公司 | 2021-02-05 | — | — | CN | claimed |
| CN-106946638-B | Preparation method of 1, 3-di-tert-butyl-5- (3-methylbutyl-2-yl) benzene | 北京六合宁远科技有限公司 | 2021-01-15 | — | — | CN | claimed |
| US-20100113800-A1 | Formation of Carbon-nitrogen bond | SHASUN PHARMA SOLUTIONS LIMITED (GB) | 2010-05-06 | — | — | US | claimed |
| CN-122059975-A | Eight-membered ring condensed boron dipyrrole compound and preparation method thereof | 中国科学院宁波材料技术与工程研究所 | 2026-05-19 | — | — | CN | disclosed |
| CN-118026834-B | Preparation method of planar chiral indene metal complex with phenylindene skeleton, synthesis intermediate and catalytic application | 中山大学 | 2026-05-12 | — | — | CN | disclosed |
| EP-4508056-B1 | INDOLE-FUNCTIONALIZED BISPHOSPHORAMIDITES, METHODS FOR THE PREPARATION THEREOF, AND RHODIUM-LIGAND COMPLEX | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-05-06 | — | — | EP | disclosed |
| US-20260098005-A1 | NON-FLUORINATED RESORCINOL AND HYDROQUINONE ANALOGS AS CURING AGENTS FOR FLUOROELASTOMERS | THE CHEMOURS COMPANY FC, LLC (US) | 2026-04-09 | — | — | US | disclosed |
| EP-4720036-A1 | CYP26B1 INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF | 16380026 Canada Inc. (CA) | 2026-04-08 | — | — | EP | disclosed |
| EP-4720037-A1 | CYP26B1 INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF | 16380026 Canada Inc. (CA) | 2026-04-08 | — | — | EP | disclosed |
| US-12545834-B2 | Light-emitting device, display device, electronic device, organic compound, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2026-02-10 | — | — | US | disclosed |
| WO-2000076523-A1 | METHODS FOR MODULATING FXR RECEPTOR ACTIVITY | ALLERGAN SALES, INC. (US) | 2000-12-21 | — | — | WO | disclosed |
| WO-2000077011-A1 | ORGANOSILYL COMPOUNDS HAVING NUCLEAR HORMONE RECEPTOR MODULATING ACTIVITY | ALLERGAN SALES, INC. (US) | 2000-12-21 | — | — | WO | disclosed |
| US-6160064-A | POLYMERIZING MONOMERS IN PRESENCE OF CATALYST SYSTEM COMPRISING UNBRIDGED FLUXIONAL METALLOCENE AND COCATALYST, INTRODUCING ETHYLENE INTO SYSTEM TO INDUCE POLYMERIZATION RATE ENHANCEMENT/ELASTOMERIC PROPERTY ENHANCING EFFECTS | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2000-12-12 | — | — | US | disclosed |
| WO-2000035975-A1 | LIGANDS AND CATALYSTS FOR PRODUCING ELASTOMERIC PROPYLENE POLYMERS | BP CORPORATION NORTH AMERICA INC. (US) | 2000-06-22 | — | — | WO | disclosed |
| EP-0991675-A1 | ETHYLENE ENHANCEMENT OF PROCESSES FOR SYNTHESIS OF HIGH MELTING THERMOPLASTIC ELASTOMERIC $g(a)-OLEFIN POLYMERS (PRE/EPE EFFECTS) | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2000-04-12 | — | — | EP | disclosed |
| WO-1998057996-A1 | ETHYLENE ENHANCEMENT OF PROCESSES FOR SYNTHESIS OF HIGH MELTING THERMOPLASTIC ELASTOMERIC α-OLEFIN POLYMERS (PRE/EPE EFFECTS) | THE BOARD OF TRUSTEES OF THE LELAND STANFORD, JR. UNIVERSITY (US) | 1998-12-23 | — | — | WO | disclosed |
| US-4708966-A | SUBSTITUTED DI-TERT-BUTYL PHENOL DERIVATIVES | THE PROCTER & GAMBLE COMPANY (US) | 1987-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260098005-A1 | NON-FLUORINATED RESORCINOL AND HYDROQUINONE ANALOGS AS CURING AGENTS FOR FLUOROELASTOMERS | CBR1, NAF1, CBR3 | GABRA1 2347/4885GABRB2 2591/4885POLB 456/4885 |
| US-20100113800-A1 | Formation of Carbon-nitrogen bond | AOC1, NES, NISCH | GABRA1 2065/4885GABRB2 2011/4885POLB 1517/4885 |
| US-12545834-B2 | Light-emitting device, display device, electronic device, organic compound, and lighting device | TLL1, L1CAM, MAP1LC3A | GABRA1 742/4885GABRB2 1177/4885POLB 3955/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.